1. Antihypertensive therapy with MK 421: angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade;Biollaz, J.; Brunner, H.R.; Gavras, I.; Waeber, B.; Gavras, H.;Jf Cardiovasc Pharmacol,1982
2. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Eur HeartJ';Turini, G.A.; Waeber, B.; Brunner, H.R.,1983
3. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system;Biollaz, J.; Schelling, J.L.; Jacot des Combes, B.;Br J Clin Pharmacol,1982
4. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril;Waeber, B.; Brunner, H.R.; Brunner, D.B.; Curtet, A.L.; Turini, G.A.; Gavras, H.;Hypertension,1980
5. Expert Committee on Cardiovascular Disease and Hypertension. Hypertension and coronary heart disease: classification and criteria for epidemiological studies. WHO Tech Rep Ser 1959; No 168